Steve is an experienced consultant and executive with over 20 years of experience in the life sciences industry. He has held several key industry roles, including head of new product planning, commercial analytics and business development, where he has focused on commercial strategy across the entire lifecycle of pharmaceutical product development. For the past 7 years, Steve has been actively discussing AI and machine learning projects and initiatives with pharma clients and has broad expertise in helping companies think about how to apply advanced analytics, including AIML, to solve commercial challenges. Steve has worked with hundreds of life sciences companies, which provides him with a broad strategic perspective on bringing complex and innovative life sciences technologies to market.

Steve received his MBA from the Wharton School at the University of Pennsylvania. In his free time, Steve enjoys cooking and traveling with his family, playing tennis and mountain biking.

Steve Laux will be speaking at ISPOR US 2024 on Monday, May 06, 2024. His presentation is titled Harnessing the Power of AI: Revolutionizing HEOR and Market Access.